Evidence map›Paper›PMID 18664597›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2008

Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue.

Susan A Phillips, Theodore P Ciaraldi, Deborah K Oh, Michelle K Savu, Robert R Henry

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  13. Article
  14. Article
  15. Review
  16. Assembly of adiponectin oligomers.Reviews in endocrine & metabolic disorders · 2014
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Susan A PhillipsVeterans Affairs San Diego Healthcare System, La Jolla, California 92161, USA. saphillips@ucsd.edu
Theodore P Ciaraldi
Deborah K Oh
Michelle K Savu
Robert R Henry
VA San Diego Healthcare System · US

Funding

ZOVIRAX CREAM TO TREAT HERPES LABIALIS IN ADOLESCENTSM01RR000827 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, R JEFFREY · 1985 to 2010
$74.3M
Muscle-Fat Communication and Metabolic ImpactK08DK061987 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PHILLIPS, SUSAN ALEXANDRA · 2002 to 2006
$610k
NCRR NIH HHS M01 RR000827NCRR NIH HHS M01-RR-00827NIDDK NIH HHS K08 DK061987NIDDK NIH HHS KO8-DK-061987NIDDK NIH HHS R01-DK-258291
6 · The paper itself

Abstract

The subcutaneous (S) and visceral (V) adipose tissue (AT) depots are increasingly recognized as distinct. To test the hypothesis that depot differences exist for adiponectin, fresh and cultured human VAT and SAT from obese type 2 diabetic (T2D) and obese nondiabetic (ND) subjects was examined to determine whether differences in adiponectin content and secretion occurred as a function of depot studied, diabetic status, and response to thiazolidinedione treatment. VAT and SAT were obtained by biopsy and AT explants cultured in defined media for 7 days. Protein expression was assessed by Western blot. Adiponectin content of conditioned medium was determined by radioimmunoassay. Diabetic status had no effect on adiponectin secretion over days 0-2 of culture. In ND SAT, secretion fell over days 2-4 but was sustained at greater levels vs. T2D SAT. In both ND and T2D VAT, adiponectin secretion was low, similar to T2D SAT. Over the 7-day culture period, cellular adiponectin increased in ND SAT and VAT; it remained unchanged in T2D SAT and VAT. Pioglitazone increased adiponectin secretion and content in all SAT. Pioglitazone failed to increase adiponectin secretion from either ND or T2D VAT and increased cellular content only in ND VAT. AT depot differences exist in the secretion of adiponectin and responsiveness to thiazolidinedione treatment. These data suggest that SAT, not VAT, appears to be the major contributor to increased circulating adiponectin levels in response to pioglitazone treatment.

Indexed as

AdipocytesAdiponectinAdipose TissueAdultCytokinesDiabetes ComplicationsDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMaleObesityOrgan Culture TechniquesPioglitazoneThiazolidinedionesAdiponectinCytokinesHypoglycemic AgentsPioglitazoneThiazolidinediones

Identifiers

PMID18664597
PMCPMC2575897
OpenAlexW2109034124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.